Standridge, RT; Howell, HG; Tilson, HA; Chamberlain, JH; Holava, HM; Gylys, JA; Partyka, RA; Shulgin, AT. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes. J. Med. Chem., 1 Jan 1980, 23 (2), 154–162. 1.1 MB. https://doi.org/10.1021/jm00176a010 #9a
Shulgin, AT. Treatment of senile geriatric patients to restore performance. Patent US 4034113, 5 Jul 1977. 519 kB.
Hyperlab. Hyperlab new compounds. 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.
Cunningham, MJ; Bock, HA; Serrano, IC; Bechand, B; Vidyadhara, DJ; Bonniwell, EM; Lankri, D; Duggan, P; Nazarova, AL; Cao, AB; Calkins, MM; Khirsariya, P; Hwu, C; Katritch, V; Chandra, SS; McCorvy, JD; Sames, D. Pharmacological mechanism of the non-hallucinogenic 5-HT2A agonist Ariadne and analogs. ACS Chem. Neurosci., 15 Dec 2022, n/a. 15.3 MB. https://doi.org/10.1021/acschemneuro.2c00597 #42 MS,NMR,other
Kruegel, AC. Phenalkylamines and methods of making and using the same. Patent WO 2022/192781 A1, 15 Sep 2022. 22.8 MB. #63i LC,MS,NMR
4-Butyl-2,5-dimethoxyamphetamine · DOBU
4-Isobutyl-2,5-dimethoxyamphetamine · DOIB
4-tert-Butyl-2,5-dimethoxyamphetamine · DOTB
4-sec-Butyl-2,5-dimethoxyamphetamine · DOSB · DOSBu
2,5-DNNEA · N,N-Diethyl-2,5-dimethoxyamphetamine · DEDMA
α,α,β,β-Tetramethyl-2,5-dimethoxy-4-methylphenethylamine · α,β,β-Me-DOM
3,4-Diethyl-2,5-dimethoxyamphetamine · G-22
4CD-25DIETO · α-Ethyl-2,5-diethoxy-4-methylphenethylamine